A detailed history of Allstate Investment Management CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Allstate Investment Management CO holds 10,257 shares of EXAS stock, worth $609,265. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,257
Holding current value
$609,265
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $311,299 - $545,159
10,257 New
10,257 $0

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Allstate Investment Management CO Portfolio

Follow Allstate Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Investment Management CO with notifications on news.